Artículo de revista
Economic benefits of treating medication-overuse headache – results from the multicenter COMOESTAS project
Fecha
2019Registro en:
Cephalalgia, Volumen 39, Issue 2, 2019, Pages 274-285
14682982
03331024
10.1177/0333102418786265
Autor
Jellestad, Pernille Linde
Carlsen, Louise Ninett
Westergaard, Maria Lurenda
Munksgaard, Signe Bruun
Bendtsen, Lars
Lainez, Miguel
Fadic, Ricardo
Katsarava, Zaza
Goicochea, Maria Teresa
Spadafora, Santiago
Jensen, Rigmor Højland
Nappi, Giuseppe
Tassorelli,
Institución
Resumen
© International Headache Society 2018.Background: Medication-overuse headache is a costly disease for individuals and society. Objective: To estimate the impact of medication-overuse headache treatment on direct and indirect headache-related health care costs. Methods: This prospective longitudinal study was part of the COMOESTAS project (COntinuous MOnitoring of Medication Overuse Headache in Europe and Latin America: development and STAndardization of an Alert and decision support System). Patients with medication-overuse headache were included from four European and two Latin American headache centers. Costs of acute medication, costs of health care services, and measurements of productivity were calculated at baseline and at 6-month follow-up Treatment consisted of overused drug withdrawal with optional preventive medication. Results: A total of 475 patients (71%) completed treatment and were followed up for 6 months. Direct health care costs were on average reduced significantly b